Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 231

    1.

    Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

    Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM.

    Diabetes Care. 2002 Nov;25(11):2016-21.PMID: 12401749 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.

    Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M.

    Food Nutr Bull. 2009 Jun;30(2):161-70.PMID: 19689095 [PubMed - indexed for MEDLINE]Related articles

    3.

    Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

    Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC; ADOPT Study Group.

    Diabetes. 2006 Aug;55(8):2357-64.PMID: 16873701 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

    Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT.

    Diabetologia. 2004 Aug;47(8):1403-10. Epub 2004 Jul 28.PMID: 15309290 [PubMed - indexed for MEDLINE]Related articles

    5.

    Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.

    Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W, Hanefeld M.

    Metabolism. 2002 Jun;51(6):743-9.PMID: 12037728 [PubMed - indexed for MEDLINE]Related articles

    6.

    Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors.

    Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J, Müller MJ.

    Int J Obes (Lond). 2006 Mar;30(3):475-83.PMID: 16261188 [PubMed - indexed for MEDLINE]Related articles

    8.

    C-reactive protein is elevated in obese patients with the metabolic syndrome.

    Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, Goldberg R.

    Diabetes Res Clin Pract. 2006 Jan;71(1):92-100. Epub 2005 Jul 5.PMID: 16002176 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Association between C-reactive protein level and metabolic syndrome and components thereof]

    Bao YQ, Jia WP, Chen L, Lu JX, Xiang KS.

    Zhonghua Yi Xue Za Zhi. 2006 Aug 15;86(30):2105-9. Chinese. PMID: 17064612 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study.

    Nakanishi N, Shiraishi T, Wada M.

    Intern Med. 2005 Jun;44(6):542-7.PMID: 16020877 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women.

    Browning LM, Jebb SA, Mishra GD, Cooke JH, O'Connell MA, Crook MA, Krebs JD.

    Int J Obes Relat Metab Disord. 2004 Aug;28(8):1004-10.PMID: 15211367 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.

    González AS, Guerrero DB, Soto MB, Díaz SP, Martinez-Olmos M, Vidal O.

    Eur J Clin Nutr. 2006 Jun;60(6):802-9. Epub 2006 Feb 22.PMID: 16493453 [PubMed - indexed for MEDLINE]Related articles

    13.

    Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.

    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.

    Diabetes Care. 2005 Oct;28(10):2525-30.PMID: 16186291 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.

    Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K.

    Atherosclerosis. 2003 Sep;170(1):79-86.PMID: 12957685 [PubMed - indexed for MEDLINE]Related articles

    16.

    Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.

    Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G.

    Atherosclerosis. 2007 Mar;191(1):182-90. Epub 2006 May 6.PMID: 16678831 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cardiometabolic risk among African American women: a pilot study.

    Appel SJ, Oster RA, Floyd NA, Ovalle F.

    J Cardiovasc Nurs. 2009 Mar-Apr;24(2):140-50.PMID: 19242280 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.

    Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R.

    Diabetes Care. 2005 Mar;28(3):690-3.PMID: 15735209 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.

    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.

    Gynecol Endocrinol. 2007 Sep;23(9):505-10.PMID: 17852421 [PubMed - indexed for MEDLINE]Related articles

    20.

    Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

    Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V.

    Metabolism. 2005 Apr;54(4):476-81.PMID: 15798954 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data